Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_2040232
Proper Citation: (Alomone Labs Cat# ACC-037, RRID:AB_2040232)
Target Antigen: TRPA1 Channel
Host Organism: rabbit
Clonality: polyclonal
Comments: Useful for Western Blot, Immunohistochemistry, Immunocytochemistry, Immunoprecipitation, Indirect Flow Cytometry, Live Cell Imaging
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Anti-TRPA1 (extracellular) Antibody.
Issue
Please see attached publication that shows this antibody is unable to recognise overexpressed TRPA1 by western blotting or immunoflourescence in 3 separate lots of the antibody. It also shows that when immunocapture mass spec is performed with samples known to contain TRPA1 (as confirmed using better performing antibodies), the main target is vimentin, and TRPA1 is not pulled down. Western blotting further confirms strong reactivity to vimentin, and sequence analysis of the immunising peptide confirms significant overlap with vimentin. In summary, multiple lots of this antibody could not recognise TRPA1. It did strongly react to vimentin (a higher expressed protein).
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.